All Questions
The National Genome Program focuses on achieving health-related objectives, specifically by identifying genetic mutations and variations that can contribute to early diagnosis and help prevent serious complications of many genetic diseases. Additionally, the program assesses family reproductive health in terms of genetic predisposition.
It does not provide any information related to ethnic backgrounds or ancestry.
The results of genome analysis are highly confidential, and participants will be personally contacted once their sample analysis is completed by the genome team.
Currently, the National Genome Center's projects are survey research initiatives. However, the center is committed to the responsibility of sharing results that indicate urgent health concerns for which preventive or proactive treatment plans are available.
The Bahraini Genome Program is a survey research initiative that categorizes participants into different groups and phases. In the first phase, 6,000 samples have been analyzed in collaboration with Harvard University, USA. This initial collaboration is expected to be completed by the end of 2024. Participants will receive their individual results once the analysis and classification of findings are finalized by a team of specialized physicians. The team will first reach out to individuals whose results indicate the need for further follow-up and genetic counseling.
As for the second phase, 100,000 samples will be analyzed locally in progressive stages. The public will be regularly updated on the results and developments as they unfold.